JAVIER
ARISTEGUI FERNANDEZ
Investigador/a en el periodo 1989-2019
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario La Paz (12)
2020
-
Evaluation of the impact of the Spanish consensus document on the approach to osteoarticular infections in Spain through the Paediatrics Osteoarticular Infections Network (RIOPED)
Anales de Pediatria, Vol. 93, Núm. 5, pp. 289-296
2016
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2015
-
Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 10, pp. 2359-2369
2014
-
Economic and psychosocial Impact of rotavirus infection in Spain: A literature review
Vaccine, Vol. 32, Núm. 30, pp. 3740-3751
-
Predictive factors of severe multilobar pneumonia and shock in patients with influenza
Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307
2013
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439
-
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745
2011
-
Combined haemophilus influenzae type B-neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines
Pediatric Infectious Disease Journal, Vol. 30, Núm. 11
-
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
Vaccine, Vol. 29, Núm. 26, pp. 4353-4361
2010
-
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
Vaccine, Vol. 28, Núm. 36, pp. 5837-5844
2002
-
Meningitis neumocócica en niños Españoles: Incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico
Anales Espanoles de Pediatria, Vol. 57, Núm. 4, pp. 295-300